RETRACTED: Tanshinone IIA Induces Apoptosis in Human Oral Cancer KB Cells through a Mitochondria-Dependent Pathway (Retracted article. See vol. 0, art no 949485, 2017)

被引:14
作者
Tseng, Pao-Yu [1 ]
Lu, Wei-Cheng [2 ]
Hsieh, Ming-Ju [2 ,3 ,4 ]
Chien, Su-Yu [5 ,6 ,7 ]
Chen, Mu-Kuan [1 ,3 ]
机构
[1] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua 500, Taiwan
[2] Changhua Christian Hosp, Canc Res Ctr, Changhua 500, Taiwan
[3] Chung Shan Med Univ, Inst Med, Taichung 500, Taiwan
[4] Chung Shan Med Univ, Sch Optometry, Taichung 402, Taiwan
[5] Changhua Christian Hosp, Dept Pharm, 135 Nanxiao St, Changhua 500, Taiwan
[6] China Med Univ, Sch Pharm, Taichung 404, Taiwan
[7] Chang Jung Christian Univ, Coll Hlth Sci, Tainan 711, Taiwan
关键词
SALVIA-MILTIORRHIZA BUNGE; ADVANCED HEAD; RADIATION-THERAPY; PHASE-III; DEATH; CHEMORADIOTHERAPY; FLUOROURACIL; CHEMOTHERAPY; INDUCTION; CISPLATIN;
D O I
10.1155/2014/540516
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Tanshinone IIA (Tan IIA), an active phytochemical in the dried root of Salvia miltiorrhiza Bunge, has shown an antiproliferative activity on various human cancer cell lines including nasopharyngeal carcinoma cells. However, the effects of Tan IIA on human oral cancer cells are still unknown. This study aimed to investigate the antiproliferative effects of Tan IIA on human oral cancer KB cells and explored the possible underlying mechanism. Treatment of KB cells with Tan IIA suppressed cell proliferation/viability and induced cell death in a dose-dependent manner through sulforhodamine B colorimetric assay. Observation of cell morphology revealed the involvement of apoptosis in the Tan IIA-induced growth inhibition on KB cells. Cell cycle analysis showed a cell cycle arrest in G(2)/M phase on Tan IIA-treated cells. The dissipation of mitochondrial membrane potential observed by flow cytometry and the expression of activated caspases with the cleaved poly (ADP-ribose) polymerase under immunoblotting analysis indicated that Tan IIA-induced apoptosis in KB cells was mediated through the mitochondria-dependent caspase pathway. These observations suggested that Tan IIA could be a potential anticancer agent for oral cancer.
引用
收藏
页数:7
相关论文
共 37 条
[1]   Life-or-death decisions by the Bcl-2 protein family [J].
Adams, JM ;
Cory, S .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (01) :61-66
[2]   Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer [J].
Adelstein, DJ ;
Li, Y ;
Adams, GL ;
Wagner, H ;
Kish, JA ;
Ensley, JF ;
Schuller, DE ;
Forastiere, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :92-98
[3]   The death effector domain protein family [J].
Barnhart, BC ;
Lee, JC ;
Alappat, EC ;
Peter, ME .
ONCOGENE, 2003, 22 (53) :8634-8644
[4]   Microtubule-targeted anticancer agents and apoptosis [J].
Bhalla, KN .
ONCOGENE, 2003, 22 (56) :9075-9086
[5]   Biochemical pathways of caspase activation during apoptosis [J].
Budihardjo, I ;
Oliver, H ;
Lutter, M ;
Luo, X ;
Wang, XD .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :269-290
[6]  
Chen Ren-zhao, 2007, Dongbei Shida Xuebao (Ziran Kexue Ban), V39, P1
[7]   Clinical pharmacokinetics of docetaxel [J].
Clarke, SJ ;
Rivory, LP .
CLINICAL PHARMACOKINETICS, 1999, 36 (02) :99-114
[8]  
Gansler T, 2010, CA-CANCER J CLIN, V60, P1, DOI [10.3322/caac.20073, 10.3322/caac.20049]
[9]   Mitochondria and apoptosis [J].
Green, DR ;
Reed, JC .
SCIENCE, 1998, 281 (5381) :1309-1312
[10]   Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer [J].
Hitt, R ;
López-Pousa, A ;
Martínez-Trufero, J ;
Escrig, V ;
Carles, J ;
Rizo, A ;
Isla, D ;
Vega, ME ;
Martí, JL ;
Lobo, F ;
Pastor, P ;
Valentí, V ;
Belón, J ;
Sánchez, MA ;
Chaib, C ;
Pallarés, C ;
Antón, A ;
Cervantes, A ;
Paz-Ares, L ;
Cortés-Funes, H .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8636-8645